ABMCAmerican Bio Medica Corp.

About American Bio Medica Corp. (ABMC)

American Bio Medica Corp. (ABMC) is a Diagnostics & Research company headquartered in Kinderhook, NY, United States whose shares trade over-the-counter on the Expert Market tier.

American Bio Medica Corporation is a biotechnology company that develops, manufactures and markets accurate, cost-effective immunoassay test kits, including some of the world's most effective point-of-collection tests for drugs of abuse.

Products and services

American Bio Medica Corporation manufactures and markets accurate, cost-effective immunoassay test kits; primarily point of collection tests for drugs of abuse. ABMC also provides contract manufacturing services related to certain infectious diseases; such as malaria and RSV and, distributes rapid tests to detect Covid-19 antibodies and rapid Covid-19 antigen tests.

ABMC key facts

Ticker symbol

ABMC

Market tier

Expert Market

Sector

Healthcare

Industry

Diagnostics & Research

Headquarters

Kinderhook, NY, United States

Country of incorporation

US

Employees

42

Estimated market cap

$4.8K (as of Apr 15, 2025)

Shares outstanding

48,098,476

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

American Bio Medica Corp. leadership

• Jean Neff — Corporate Secretary

Explore more: Diagnostics & Research stocks · Healthcare sector · Expert Market stocks · OTC stocks starting with A